DNLI
Price
$29.63
Change
-$0.26 (-0.87%)
Updated
Nov 13 closing price
109 days until earnings call
PEPG
Price
$4.55
Change
+$0.01 (+0.22%)
Updated
Nov 13 closing price
126 days until earnings call
Ad is loading...

DNLI vs PEPG

Header iconDNLI vs PEPG Comparison
Open Charts DNLI vs PEPGBanner chart's image
Denali Therapeutics
Price$29.63
Change-$0.26 (-0.87%)
Volume$1.59M
CapitalizationN/A
PepGen
Price$4.55
Change+$0.01 (+0.22%)
Volume$1.36M
CapitalizationN/A
DNLI vs PEPG Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
DNLI vs. PEPG commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and PEPG is a Sell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (DNLI: $29.64 vs. PEPG: $4.58)
Brand notoriety: DNLI and PEPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 184% vs. PEPG: 1348%
Market capitalization -- DNLI: $4.3B vs. PEPG: $149.29M
DNLI [@Biotechnology] is valued at $4.3B. PEPG’s [@Biotechnology] market capitalization is $149.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whilePEPG’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • PEPG’s FA Score: 1 green, 4 red.
According to our system of comparison, PEPG is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 6 TA indicator(s) are bullish while PEPG’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 6 bullish, 4 bearish.
  • PEPG’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than PEPG.

Price Growth

DNLI (@Biotechnology) experienced а +0.30% price change this week, while PEPG (@Biotechnology) price change was -36.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 03, 2025.

PEPG is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($4.3B) has a higher market cap than PEPG($149M). DNLI YTD gains are higher at: 38.117 vs. PEPG (-32.647). PEPG has higher annual earnings (EBITDA): -92.71M vs. DNLI (-486.71M). DNLI has more cash in the bank: 896M vs. PEPG (161M). PEPG has less debt than DNLI: PEPG (19.4M) vs DNLI (48.8M). DNLI has higher revenues than PEPG: DNLI (1.27M) vs PEPG (0).
DNLIPEPGDNLI / PEPG
Capitalization4.3B149M2,888%
EBITDA-486.71M-92.71M525%
Gain YTD38.117-32.647-117%
P/E RatioN/AN/A-
Revenue1.27M0-
Total Cash896M161M557%
Total Debt48.8M19.4M252%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIPEPG
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAMPX15.20N/A
N/A
GS Energy Infrastructure Fd P
MSCUX12.53N/A
N/A
Morgan Stanley American Resilience A
ELFNX99.28-0.02
-0.02%
Elfun Trusts
JCVSX37.39-0.03
-0.08%
JHancock Classic Value R2
ABNIX30.72-0.40
-1.29%
abrdn International Small Cp Inst

PEPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEPG has been loosely correlated with PRTA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PEPG jumps, then PRTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
+0.88%
PRTA - PEPG
53%
Loosely correlated
-0.75%
ABOS - PEPG
37%
Loosely correlated
-5.42%
FGEN - PEPG
31%
Poorly correlated
-14.49%
AURA - PEPG
30%
Poorly correlated
-3.00%
DNLI - PEPG
29%
Poorly correlated
-0.84%
More